Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor-related and conventional

J Diabetes Investig. 2021 Jun;12(6):917-919. doi: 10.1111/jdi.13450. Epub 2020 Dec 7.

Abstract

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • B7-H1 Antigen
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • Immune Checkpoint Inhibitors

Grants and funding